Agilent Technologies Inc

More Details of Agilent Technologies Inc Company

Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company’s life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the cell analysis, advanced manufacturing partnerships contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, genomics and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.

Company Info

Company codeA

Company nameAgilent Technologies Inc

IPO dateNov 18, 1999

Founded at1999

CEOMr. Padraig McDonnell

Number of employees17900

Security typeOrdinary Share

Fiscal year-endNov 18

Address5301 Stevens Creek Blvd

CitySANTA CLARA

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code95051

Phone14083458886

Websitehttps://www.agilent.com/

Company codeA

IPO dateNov 18, 1999

Founded at1999

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Boon Hwee Koh

Non-Executive Independent Chairman of the Board

61.55K

+2.11%

Mr. Rodney Gonsalves

Chief Accounting Officer, Vice President, Corporate Controllership

39.42K

-4.62%

Dr. George A. Scangos, Ph.D.

Independent Director

38.35K

+4.98%

Dr. Daniel K. Podolsky, M.D.

Independent Director

35.68K

--

Mr. Dow R. Wilson

Independent Director

18.04K

+11.21%

Ms. Mala Anand

Independent Director

14.55K

+14.29%

Mr. Padraig McDonnell

Chief Executive Officer, Director

12.19K

-2.23%

Dr. Otis W. Brawley, M.D.

Independent Director

10.73K

+32.49%

Dr. Simon May

Senior Vice President, President, Diagnostics and Genomics

7.69K

+81.51%

Dr. Mikael G. Dolsten, M.D., Ph.D.

Independent Director

7.54K

+31.77%

Name

Name/Position

Position

Shareholding

Change

Mr. Boon Hwee Koh

Non-Executive Independent Chairman of the Board

61.55K

+2.11%

Mr. Rodney Gonsalves

Chief Accounting Officer, Vice President, Corporate Controllership

39.42K

-4.62%

Dr. George A. Scangos, Ph.D.

Independent Director

38.35K

+4.98%

Dr. Daniel K. Podolsky, M.D.

Independent Director

35.68K

--

Mr. Dow R. Wilson

Independent Director

18.04K

+11.21%

Ms. Mala Anand

Independent Director

14.55K

+14.29%

Revenue Breakdown

Currency: USDUpdate time: Sun, Apr 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

FY2018

By BusinessUSD

Name

Revenue

Proportion

Non-instrumentation and other

1.06B

62.82%

Instrumentation

625.00M

37.18%

By RegionUSD

Name

Revenue

Proportion

United States

669.00M

39.80%

Asia Pacific

549.00M

32.66%

Europe

463.00M

27.54%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Non-instrumentation and other

1.06B

62.82%

Instrumentation

625.00M

37.18%

Shareholder

Update time: Sat, Apr 26

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

11.59%

BlackRock Institutional Trust Company, N.A.

5.38%

State Street Global Advisors (US)

4.46%

MFS Investment Management

4.03%

Wellington Management Company, LLP

3.26%

Other

71.28%

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

11.59%

BlackRock Institutional Trust Company, N.A.

5.38%

State Street Global Advisors (US)

4.46%

MFS Investment Management

4.03%

Wellington Management Company, LLP

3.26%

Other

71.28%

Type

Shareholder

Proportion

Investment Advisor/Hedge Fund

46.50%

Investment Advisor

33.59%

Hedge Fund

3.32%

Pension Fund

1.89%

Research Firm

1.78%

Insurance Company

1.41%

Bank and Trust

1.39%

Sovereign Wealth Fund

1.29%

Family Office

0.44%

Other

8.39%

Institutional Shareholding

Update time: Sun, Jan 19

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

2096

261.86M

91.84%

-8.41M

2024Q4

2144

261.66M

91.77%

-9.44M

2024Q3

2092

261.54M

91.00%

-12.94M

2024Q2

2065

263.61M

90.36%

-18.36M

2024Q1

2066

270.62M

92.35%

-9.44M

2023Q4

2084

269.59M

92.01%

-3.30M

2023Q3

2017

262.63M

89.76%

-13.56M

2023Q2

2002

268.16M

90.78%

-20.64M

2023Q1

1985

271.86M

91.93%

-13.10M

2022Q4

1944

268.33M

90.62%

-17.98M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

33.04M

11.59%

-403.17K

-1.21%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

15.33M

5.38%

-244.77K

-1.57%

Dec 31, 2024

State Street Global Advisors (US)

12.71M

4.46%

-105.89K

-0.83%

Dec 31, 2024

MFS Investment Management

11.49M

4.03%

-3.02M

-20.80%

Dec 31, 2024

Wellington Management Company, LLP

9.31M

3.26%

+59.78K

+0.65%

Dec 31, 2024

T. Rowe Price Investment Management, Inc.

8.23M

2.89%

-6.73K

-0.08%

Dec 31, 2024

Geode Capital Management, L.L.C.

7.00M

2.46%

+53.99K

+0.78%

Dec 31, 2024

Pictet Asset Management Ltd.

5.21M

1.83%

+47.49K

+0.92%

Dec 31, 2024

Generation Investment Management LLP

4.16M

1.46%

+1.13M

+37.08%

Dec 31, 2024

State Farm Insurance Companies

3.83M

1.34%

--

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

ProShares Nanotechnology ETF

4.59%

Global X Genomics & Biotechnology ETF

4.5%

Parnassus Value Select ETF

4.12%

First Trust Water ETF

3.69%

Honeytree US Equity ETF

3.54%

VanEck Morningstar Wide Moat Growth ETF

3.42%

Global X Telemedicine & Digital Health ETF

3.31%

Madison Covered Call ETF

2.95%

Argent Mid Cap ETF

2.29%

VanEck Morningstar Wide Moat ETF

2.2%

ProShares Nanotechnology ETF

Proportion4.59%

Global X Genomics & Biotechnology ETF

Proportion4.5%

Parnassus Value Select ETF

Proportion4.12%

First Trust Water ETF

Proportion3.69%

Honeytree US Equity ETF

Proportion3.54%

VanEck Morningstar Wide Moat Growth ETF

Proportion3.42%

Global X Telemedicine & Digital Health ETF

Proportion3.31%

Madison Covered Call ETF

Proportion2.95%

Argent Mid Cap ETF

Proportion2.29%

VanEck Morningstar Wide Moat ETF

Proportion2.2%

Dividend

A total of 1.25B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Nov 20, 2024

A.NB Interim Cash Dividend of gross USD 0.248 paid on Jan 22, 2025 going ex on Dec 31, 2024 with reinvestment option

Dec 31, 2024

Jan 22, 2025

Dec 31, 2024

Sep 18, 2024

A.NB Final Cash Dividend of gross USD 0.236 paid on Oct 23, 2024 going ex on Oct 01, 2024 with reinvestment option

Oct 01, 2024

Oct 23, 2024

Oct 01, 2024

May 22, 2024

A.NB Interim Cash Dividend of gross USD 0.236 paid on Jul 24, 2024 going ex on Jul 02, 2024

Jul 02, 2024

Jul 24, 2024

Jul 02, 2024

Feb 21, 2024

A.NB Interim Cash Dividend of gross USD 0.236 paid on Apr 24, 2024 going ex on Apr 01, 2024

Apr 02, 2024

Apr 24, 2024

Apr 01, 2024

Nov 16, 2023

A.NB Interim Cash Dividend of gross USD 0.236 paid on Jan 24, 2024 going ex on Dec 29, 2023

Jan 02, 2024

Jan 24, 2024

Dec 29, 2023

Sep 21, 2023

A.NB Final Cash Dividend of gross USD 0.225 paid on Oct 25, 2023 going ex on Oct 02, 2023 with reinvestment option

Oct 03, 2023

Oct 25, 2023

Oct 02, 2023

May 18, 2023

A.NB Interim Cash Dividend of gross USD 0.225 paid on Jul 26, 2023 going ex on Jun 30, 2023 with reinvestment option

Jul 03, 2023

Jul 26, 2023

Jun 30, 2023

Feb 22, 2023

A.NB Interim Cash Dividend of gross USD 0.225 paid on Apr 26, 2023 going ex on Apr 03, 2023

Apr 04, 2023

Apr 26, 2023

Apr 03, 2023

Nov 16, 2022

A.NB Interim Cash Dividend of gross USD 0.225 paid on Jan 25, 2023 going ex on Dec 30, 2022

Jan 03, 2023

Jan 25, 2023

Dec 30, 2022

Sep 21, 2022

A.NB Final Cash Dividend of gross USD 0.21 paid on Oct 26, 2022 going ex on Oct 03, 2022

Oct 04, 2022

Oct 26, 2022

Oct 03, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

107.480USD

Agilent Technologies Inc

107.480

Overview

Company